Blau Farmaceutica SA (BLAU3)
BOV
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | ||||
総売上 | 361.63M | 366.7M | 258.2M | 364.31M | 439.84M | 429.26M | 359.68M | 465.1M |
営業利益 | 113.09M | 113.66M | 51.28M | 76M | 152.37M | 39.67M | 48.84M | 72.08M |
税引前収入 | 126.46M | 117.66M | 59.61M | 86.84M | 149.76M | 38.02M | 47.58M | 57.17M |
純利益 | 94.53M | 94.98M | 51.95M | 70.79M | 99.4M | 27.68M | 40.09M | 48.73M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 113.09M | 113.66M | 51.28M | 76M | 152.37M | 39.67M | 48.84M | 72.08M |
EBITDA | 126.58M | 119.48M | 58.11M | 84M | 164.02M | 52.23M | 60.91M | 84.9M |
年末 2023年12月31日 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
総売上 | 977.69M | 1.18B | 1.37B | 1.41B | 1.49B |
営業利益 | 301.48M | 389.13M | 456.62M | 452.19M | 329.44M |
税引前収入 | 286.36M | 353.64M | 482.47M | 468.56M | 334.23M |
純利益 | 200.24M | 254.33M | 323.86M | 363.37M | 249.81M |
優先配当 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 1.353 | 1.718 | 1.805 | 2.008 | 1.379 |
EBIT | 301.48M | 389.13M | 456.62M | 452.19M | 329.44M |
EBITDA | 327.91M | 406.31M | 478.28M | 474.44M | 368.49M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約